Detalles de la búsqueda
1.
2023 American College of Rheumatology and American Association of Hip and Knee Surgeons Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients With Symptomatic Moderate-to-Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis With Secondary Arthritis for Whom Nonoperative Therapy Is Ineffective.
J Arthroplasty
; 38(11): 2193-2201, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37778918
2.
C3 glomerulonephritis and systemic lupus erythematosus: A report of a patient treated with eculizumab and review of the literature.
Lupus
; 30(10): 1671-1678, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34192954
3.
Erratum to "2023 American College of Rheumatology and American Association of Hip and Knee Surgeons Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients With Symptomatic Moderate-to-Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis With Secondary Arthritis for Whom Nonoperative Therapy Is Ineffective" [The Journal of Arthroplasty 38 (2023) 2193-2201].
J Arthroplasty
; 39(3): 851-852, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38049357
4.
Airway surface liquid from smokers promotes bacterial growth and biofilm formation via iron-lactoferrin imbalance.
Respir Res
; 19(1): 42, 2018 03 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29524964
5.
Advances in the management of systemic lupus erythematosus.
BMJ
; 383: e073980, 2023 10 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37884289
6.
Type I Interferons in Autoimmunity: Implications in Clinical Phenotypes and Treatment Response.
J Rheumatol
; 50(9): 1103-1113, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37399470
7.
2023 American College of Rheumatology and American Association of Hip and Knee Surgeons Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients With Symptomatic Moderate-to-Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis With Secondary Arthritis for Whom Nonoperative Therapy Is Ineffective.
Arthritis Care Res (Hoboken)
; 75(11): 2227-2238, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37743767
8.
2023 American College of Rheumatology and American Association of Hip and Knee Surgeons Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients With Symptomatic Moderate-to-Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis With Secondary Arthritis for Whom Nonoperative Therapy Is Ineffective.
Arthritis Rheumatol
; 75(11): 1877-1888, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37746897
9.
The role of anticomplement therapy in lupus nephritis.
Transl Res
; 245: 1-17, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35158097
10.
Type I Interferons in Autoimmunity.
J Invest Dermatol
; 142(3 Pt B): 793-803, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35016780
11.
Interferon pathway lupus risk alleles modulate risk of death from acute COVID-19.
Transl Res
; 244: 47-55, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35114420
12.
Evaluation of Immune Response and Disease Status in Systemic Lupus Erythematosus Patients Following SARS-CoV-2 Vaccination.
Arthritis Rheumatol
; 74(2): 284-294, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34347939
13.
COVID-19 in patients with systemic lupus erythematosus: lessons learned from the inflammatory disease.
Transl Res
; 232: 13-36, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33352298
14.
T Cells in Systemic Lupus Erythematosus.
Rheum Dis Clin North Am
; 47(3): 379-393, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34215369
15.
Clinical and laboratory features of patients with focal lymphocytic sialadenitis on minor salivary gland biopsy for sicca symptoms: A single-center experience.
Medicine (Baltimore)
; 100(13): e25325, 2021 Apr 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33787627
16.
Interferon pathway lupus risk alleles modulate risk of death from acute COVID-19.
medRxiv
; 2021 Nov 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34751274
17.
Evaluation of SARS-CoV-2 IgG antibody reactivity in patients with systemic lupus erythematosus: analysis of a multi-racial and multi-ethnic cohort.
Lancet Rheumatol
; 3(8): e585-e594, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34075358
18.
Type I interferon in the pathogenesis of systemic lupus erythematosus.
Curr Opin Immunol
; 67: 87-94, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33246136
19.
Discontinuation of hydroxychloroquine in older patients with systemic lupus erythematosus: a multicenter retrospective study.
Arthritis Res Ther
; 22(1): 191, 2020 08 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-32807233
20.
Leveraging the United States Epicenter to Provide Insights on COVID-19 in Patients With Systemic Lupus Erythematosus.
Arthritis Rheumatol
; 72(12): 1971-1980, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32715660